Transcription of promoter from the human APRIL gene regulated by Sp1 and NF-kB

Neoplasma

Volumn 59, Issue 3, 2012, Pages 341-347

  Xu, J ^a   Ding, W F ^a   Shao, K K ^a   Wang, X D ^a   Wang, G H ^a   Li, H Q ^a   Wang, H M ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

APRIL; Luciferase reporter assay; NF B; Promoter; Sp1

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITHRAMYCIN; TRANSCRIPTION FACTOR SP1; 3-(4-METHYLPHENYLSULFONYL)-2-PROPENENITRILE; APRIL PROTEIN; DRUG DERIVATIVE; LUCIFERASE; MITHRAMYCIN A; NITRILE; SULFONE; TNFSF13 PROTEIN, HUMAN;

APRIL GENE; ARTICLE; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; DNA FLANKING REGION; DNA TRANSCRIPTION; GEL MOBILITY SHIFT ASSAY; GENE; GENE CONTROL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN EXPRESSION; TRANSIENT TRANSFECTION; WESTERN BLOTTING; BINDING SITE; COLORECTAL TUMOR; DNA RESPONSIVE ELEMENT; DRUG ANTAGONISM; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOLECULAR GENETICS; PROTEIN BINDING; TUMOR CELL CULTURE;

BASE SEQUENCE; BINDING SITES; COLORECTAL NEOPLASMS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUCIFERASES; MOLECULAR SEQUENCE DATA; NF-KAPPA B; NITRILES; PLICAMYCIN; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RESPONSE ELEMENTS; SEQUENCE DELETION; SP1 TRANSCRIPTION FACTOR; SULFONES; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 84863831306     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2012_044     Document Type: Article

References (27)

1. HAHNE M, KATAOKA T, SCHROTER M, HOFMANN K, IRMLER M et al. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med 1998; 188: 1185-1190. http://dx.doi.org/10.1084/jem.188.6.1185
2. RENNERT P, SCHNEIDER P, CACHERO TG, THOMPSON J, TRABACH L et al. A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth. J Exp Med 2000; 192: 1677-1684. http://dx.doi.org/10.1084/je
3. WU Y, BRESSETTE D, CARRELL JA, KAUFMAN T, FENG P et al. Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS. J Biol Chem 2000; 275: 35478-35485. http://dx.doi.org/10.1074/jbc.M005224200
4. HENDRIKS J, PLANELLES L, DE JONG-ODDING J, HARDENBERG G, PALS ST et al. Heparan sulfate proteglycans binding promotes APRIL-induced tumor cell proliferation. Cell Death Differ 2005; 12: 637-648. http://dx.doi.org/10.1038/sj.cdd.4401647
5. MACKAY F, SCHNEIDER P, RENNERT P, BROWNING J. BAFF AND APRIL: a tutorial on B cell survival. Annu Rev Immunol 2003; 21: 231-264. http://dx.doi.org/10.1146/annurev.immunol.21.120601.141152
6. KELLY K, MANOS E, JENSEN G, NADAULD L, JONES DA. APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death. Cancer Res 2000; 60: 1021-1027.
7. DING W, WANG J, SUN B, JU S, YUAN H et al. APRIL knockdown suppresses migration and invasion of human colon carcinoma cells. Clin Biochem 2009; 42: 1694-1698. http://dx.doi.org/10.1016/j.clinbiochem.2009.06.019
8. WANG F, DING W, WANG J, JING R, WANG X et al. Identification of microRNA-target interaction in APRIL-knockdown colorectal cancer cells. Cancer Gene Ther 2011; 18: 500-509. http://dx.doi.org/10.1038/cgt.2011.19
9. HANNENHALLI S, LEVY S. Promoter prediction in the human genome. Bioinformatics 2001; 17: S90-S96. http://dx.doi.org/10.1093/bioinformatics/17.suppl_1.S90
10. ZHAO Z, HAN L. CpG islands: algorithms and applications in methylation studies. Biochem Biophys Res Commun 2009; 382: 643-64 http://dx.doi.org/10.1016/j.bbrc.2009.03.076
11. PIERCE JW, SCHOENLEBER R, JESMOK G, BEST J, MOORE SA et al. Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 1997; 272: 21096-21103. http://dx.doi.org/10.1074/jbc.272.34.21096
12. BLUME SW, SNYDER RC, RAY R, THOMAS S, KOLLER CA et al. Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J Clin Invest 1991; 88: 1613-1621. http://dx.doi.org/10.1172/JCI115474
13. ROOSNEK E, BURJANADZE M, DIETRICH PY, MATTHES T, PASSWEG J et al. Tumors that look for their springtime in APRIL. Crit Rev Oncol Hematol 2009; 72: 91-97. http://dx.doi.org/10.1016/j.critrevonc.2009.01.006
14. BREATHNACH R, CHAMBON P. Organization and expression of eucaryotic split genes coding for proteins. Annu Rev Biochem 1981; 50: 349-383. http://dx.doi.org/10.1146/annurev.bi.50.070181.002025
15. SUSKE G. The Sp-family of transcription factors. Gene 1999; 238: 291-300. http://dx.doi.org/10.1016/S0378-1119(99)00357-1
16. BRIGGS MR, KADONAGA JT, BELL SP, TJIAN R. Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. Science 1986; 234: 47-52.
17. WIERSTRA I. Sp1: emerging roles--beyond constitutive activation of TATA-less housekeeping genes. Biochem Biophys Res Commun 2008; 372: 1-13. http://dx.doi.org/10.1016/j.bbrc.2008.03.074
18. SAFE S, ABDELRAHIM M. Sp transcription factor family and its role in cancer. Eur J Cancer 2005; 41: 2438-2448. http://dx.doi.org/10.1016/j.ejca.2005.08.006
19. GARTEL AL, GOUFMAN E, NAJMABADI F, TYNER AL. Sp1 and Sp3 activate p21 (WAF1/CIP1) gene transcription in the Caco-2 colon adenocarcinoma cell line. Oncogene 2000; 19: 5182-5188. http://dx.doi.org/10.1038/sj.onc.1203900
20. ZHU GH, LENZI M, SCHWARTZ EL. The Sp1 transcription factor contributes to the tumor necrosis factor-induced expression of the angiogenic factor thymidine phosphorylase in human colon carcinoma cells. Oncogene 2002; 21: 8477-8485. http://dx.doi.org/10.1038/sj.onc.1206030
21. TAKAMI Y, RUSSELL MB, GAO C, MI Z, GUO H et al. Sp1 regulates osteopontin expression in SW480 human colon adenocarcinoma cells. Surgery 2007; 142: 163-169. http://dx.doi.org/10.1016/j.surg.2007.02.015
22. DONG W, SHEN R, WANG Q, GAO Y, QI X et al. Sp1 upregulates expression of TRF2 and TRF2 inhibition reduces tumorigenesis in human colorectal carcinoma cells. Cancer Biol Ther 2009; 8: 2166-2174. http://dx.doi.org/10.4161/cbt.8.22.9880
23. BALDWIN AS JR. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649-683. http://dx.doi.org/10.1146/annurev.immunol.14.1.649
24. CHEN F, CASTRANOVA V, SHI X, DEMERS LM. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 1999; 45: 7-17.
25. KARIN M. Nuclear factor-kappaB in cancer development and progression. Nature 2006; 441: 431-436. http://dx.doi.org/10.1038/nature04870
26. VERMEULEN L, DE WILDE G, VAN DAMME P, VANDEN BERGHE W, HAEGEMAN G. Transcriptional activation of the NF-kappaB p65 subunit by mitogen-and stress-activated protein kinase-1 (MSK1). EMBO J 2003; 22: 1313-1324. http://dx.doi.org/10.1093/emboj/cdg139
27. MARSTERS SA, YAN M, PITTI RM, HAAS PE, DIXIT VM et al. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr Biol 2000; 10: 785-788. http://dx.doi.org/10.1016/S0960-9822(00)00566-2